Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Envaste is a private medical device company focused on the design, development, manufacture, and distribution of minimally invasive instruments for therapeutic urology and endoscopy. The company appears to market commercial single-use and catheter-based products including ureteral and nephrostomy balloon dilators, ureteral access sheaths, endoscopic balloon dilators, and stone extraction balloons. Its product portfolio is oriented toward procedural applications such as urinary tract dilation, nephrostomy tract access, ureteroscopy support, and endoscopic interventions in gastroenterology. Envaste is based in Moka, Mauritius, and has been described by multiple business databases as an active, for-profit healthcare company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Envaste.